e-learning
resources
Vienna 2009
Wednesday, 16.09.2009
Multi/extensively-drug resistant tuberculosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Local artificial atelectasis in treatment of end-stage XDR cavitary tuberculosis
O. Lovacheva, I. Sivokozov, T. Bagdasaryan, Y. Kossiy, A. Ergeshov (Moscow, Russian Federation)
Source:
Annual Congress 2009 - Multi/extensively-drug resistant tuberculosis
Session:
Multi/extensively-drug resistant tuberculosis
Session type:
Oral Presentation
Number:
4451
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
O. Lovacheva, I. Sivokozov, T. Bagdasaryan, Y. Kossiy, A. Ergeshov (Moscow, Russian Federation). Local artificial atelectasis in treatment of end-stage XDR cavitary tuberculosis. Eur Respir J 2009; 34: Suppl. 53, 4451
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on unprecedented progress in shortening treatment for TB: Evidence to date, and future possibilities
Related content which might interest you:
The efficiency of surgical treatment for multidrug-resistant pulmonary and pleural tuberculosis
Source: International Congress 2016 – Surgical strategy for complex diseases
Year: 2016
Surgery in cavitary pulmonary tuberculosis
Source: Annual Congress 2008 - Outcomes of tuberculosis treatment
Year: 2008
The rational chemotherapy of new smear-positive lung tuberculosis with extended cavitary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 9s
Year: 2006
Valvular bronchial blocking in the treatment of cavitary pulmonary tuberculosis (CPTB)
Source: International Congress 2016 – Bronchoscopy: from diagnostic to treating air leaks
Year: 2016
Combined collapse therapy in the treatment of cavitary pulmonary tuberculosis (CPTB)
Source: International Congress 2015 – Management of TB: a patient focus
Year: 2015
Effectiveness of thoracoplasty at disseminated drug-resistant fibrous-cavernous pulmonary tuberculosis
Source: Annual Congress 2010 - Special treatment options in tuberculosis
Year: 2010
The prevalence of pulmonary parenchymal tuberculosis in patients with tuberculous pleuritis
Source: Eur Respir J 2005; 26: Suppl. 49, 690s
Year: 2005
Farmer‘s lung or miliary tuberculosis?
Source: Eur Respir J 2005; 26: Suppl. 49, 600s
Year: 2005
Exposure to mycobacterium tuberculosis during bronchoscopy in patients with unexpected pulmonary tuberculosis
Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis
Year: 2016
MOTT as a cause of treatment failure in pulmonary tuberculosis
Source: Annual Congress 2013 –Non-tuberculous mycobacteria: clinical management
Year: 2013
TB, NTM and bronchiectasis
Source: ERS Skills Course 2016
Year: 2016
Pleuropulmonectomy with fibrocavernous tuberculosis of lungs and empyema of pleura
Source: Eur Respir J 2003; 22: Suppl. 45, 523s
Year: 2003
A randomized study of the bronchoscopic valve blockade of the affected part of the lung in the complex treatment of patients with cavitary drug-resistant pulmonary tuberculosis with treatment failure
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management II
Year: 2013
Pulmonary involvement in extrapulmonary tuberculosis patients
Source: Annual Congress 2011 - Pulmonary and extrapulmonary tuberculosis
Year: 2011
Crohn‘s disease or extrapulmonary tuberculosis?
Source: Annual Congress 2009 - Extrapulmonary tuberculosis and non-tuberculous-mycobacteria (NTM) infections
Year: 2009
Frequency of endobronchial tuberculosis in patients with active pulmonary tuberculosis is high
Source: Eur Respir J 2004; 24: Suppl. 48, 33s
Year: 2004
Surgical treatment of first-found destructive pulmonary tuberculosis
Source: Annual Congress 2012 - Tuberculosis: invasive diagnostic and therapeutic interventions
Year: 2012
Extra pulmonary tuberculosis in children with pulmonary tuberculosis
Source: Eur Respir J 2007; 30: Suppl. 51, 655s
Year: 2007
Management of secondary pneumothorax in lung infections with
Mycobacterium tuberculosis
Source: Eur Respir J 2001; 18: Suppl. 33, 525s
Year: 2001
Analysis of pulmonary and extra-pulmonary tuberculosis patients registered in a local dispensary
Source: Eur Respir J 2004; 24: Suppl. 48, 417s
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept